Giusi Moffa
Characteristics and survival of patients with cancer with intended off-label use-a cohort study.
Schmitt A, Walter M, Herbrand A, Jörger M, Moffa G, Novak U, Hemkens L, Kasenda B. Characteristics and survival of patients with cancer with intended off-label use-a cohort study. BMJ Open 2022; 12:e060453.
24.05.2022Characteristics and survival of patients with cancer with intended off-label use-a cohort study.
24.05.2022BMJ Open 2022; 12:e060453
Schmitt Andreas Michael, Walter Martin A, Herbrand Amanda Katherina, Jörger Markus, Moffa Giusi, Novak Urban, Hemkens Lars G, Kasenda Benjamin
Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs
Herbrand A, Hemkens L, Novak U, Moffa G, Jörger M, Hoogkamer A, Diem S, Goldkuhle M, Ewald H, Briel M, Schmitt A, Kasenda B. Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs. JAMA Netw Open 2021; 4:e210380.
01.03.2021Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs
01.03.2021JAMA Netw Open 2021; 4:e210380
Herbrand Amanda Katherina, Hemkens Lars G, Novak Urban, Moffa Giusi, Jörger Markus, Hoogkamer Anouk, Diem Stefan, Goldkuhle Marius, Ewald Hannah, Briel Matthias, Schmitt Andreas M, Kasenda Benjamin